L. plantarum (HOWARU Lp-202195(TM))
L. plantarum (HOWARU Lp-202195(TM)), NPN 80121721: natural health product licensed in Canada. Medicinal ingredients: Lactiplantibacillus plantarum.
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Lactiplantibacillus plantarum Source : ATCC 202195 | 1 Milliards d'UFC | Not calculated |
| Lactiplantibacillus plantarum Source : Lactiplantibacillus Plantarum - Cellule entière | 1 Milliards d'UFC | Not calculated |
Non-medicinal ingredients
Trehalose, Maltodextrine, Phosphate de dipotassium, Phosphate de potassium, monobasique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Nourrissons | maximum: 12 months | 1 packet | 1 day |
Uses authorised in Canada
Source of probiotics. Helps support intestinal/gastrointestinal health. Could promote favourable gut flora.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Cautions and Warnings
If you have fever, vomiting, bloody diarrhea or severe abdominal pain, consult a health care practitioner prior to use. If symptoms of digestive upset occur, worsen, or persist beyond 3 days, discontinue use and consult a health care practitioner.
- Contra-Indications
Do not use this product if you have an immune-compromised condition.
Product record
- Licence holder
- Danisco USA Inc.
- NPN or DIN-HM
- 80121721
- Status
- Active licence
- Licence date
- 27 October 2022
- Revision date
- Not provided
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
Source
Official Health Canada record, licence 80121721
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “L. plantarum (HOWARU Lp-202195(TM)) (Danisco USA Inc.): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80121721-l-plantarum-howaru-lp-202195-tm, updated 27 October 2022.